These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6812915)

  • 1. [The anticoagulant effects of defibrinogenase in the normal human body].
    Yang JH
    Zhonghua Yi Xue Za Zhi; 1982 Jun; 62(6):321-3. PubMed ID: 6812915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical report on 333 cases of obstructive vascular diseases treated with defibrinogenase].
    Zhonghua Yi Xue Za Zhi; 1982 Jun; 62(6):324-7. PubMed ID: 6812916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive effects of defibrinogenase on experimental thrombosis in rats].
    Li LX
    Zhonghua Yi Xue Za Zhi; 1982 Jun; 62(6):328-9. PubMed ID: 6812917
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolation of venom from Agkistrodon acutus and assay of biological activities of thrombin-like enzyme and other fractions (author's transl)].
    Teng GQ; Yue PE; Fan WB
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):21-5. PubMed ID: 6211897
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fribrinolysis kinetics and its application.
    Wei W; Yang R; Guo T; Yang Y; Hu Y
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):111-3. PubMed ID: 17393125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
    Mohri M; Sugimoto E; Sata M; Asano T
    Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
    Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
    Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of procoagulation effect of thrombin-like enzymes from Dienagkistrodon acutus and Agkistrodon halys snake venoms.
    Wei WL; Sun JJ; Chen JS
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):527-31. PubMed ID: 9863148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of factor XII (Hagemann's) in activation of the blood anticoagulation system].
    Kudriashov BA; Kalishevskaia TM; Baskova IP; Strukova SM; Kovaleva TN
    Vopr Med Khim; 1969; 15(5):486-94. PubMed ID: 5368086
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin as procoagulant and anticoagulant.
    Di Cera E
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():196-202. PubMed ID: 17635727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new anticoagulant-antidote pair: control of thrombin activity by aptamers and porphyrins.
    Joachimi A; Mayer G; Hartig JS
    J Am Chem Soc; 2007 Mar; 129(11):3036-7. PubMed ID: 17319665
    [No Abstract]   [Full Text] [Related]  

  • 15. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS
    Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.